StockData
Caris Life Sciences, Inc. logo

Caris Life Sciences, Inc. (CAI) SEC filings

CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30104% above fair value
$21.00−2.04 (-8.85%)

Close on Nov 16, 2026Market cap $5.93BP/E –Yield –

SEC filings

19 of Caris Life Sciences's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 4, 2026SEC EDGAR
Current report8-KNov 4, 2026Nov 4, 2026SEC EDGAR
Current report8-KSep 14, 2026Sep 14, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 5, 2026SEC EDGAR
Current report8-KAug 5, 2026Aug 5, 2026SEC EDGAR
Current report8-KJun 4, 2026Jun 5, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 8, 2026SEC EDGAR
Current report8-KMay 7, 2026May 7, 2026SEC EDGAR
Proxy statementDEF 14AJun 4, 2026Apr 23, 2026SEC EDGAR
Current report8-KApr 1, 2026Apr 2, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 3, 2026SEC EDGAR
Current report8-KFeb 26, 2026Feb 26, 2026SEC EDGAR
Current report8-KJan 12, 2026Jan 12, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 5, 2025SEC EDGAR
Current report8-KNov 5, 2025Nov 5, 2025SEC EDGAR
Current report8-KOct 30, 2025Oct 30, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 12, 2025SEC EDGAR
Current report8-KAug 12, 2025Aug 12, 2025SEC EDGAR
Current report8-KJun 20, 2025Jun 20, 2025SEC EDGAR

See a number that looks wrong?